Pharmafit Provence
LACRIGEL Ophthalmic gel tube/10g

Laboratoires Europhta

LACRIGEL Ophthalmic gel tube/10g

CIP / EAN code: 3400933521134

Product information from VIDAL.

Read the product information
Back to the catalogue

Product information

Find indications, dosage and precautions in the sections below.

Automatic English translation of the French VIDAL document. Original numerical values and units are retained, including decimal commas.

VIDAL
Medicines
Update of 06/02/2023

LACRIGEL®
carbomer 980


Forms and presentations

Ophthalmic gel:  Tube of 10 g.


Composition

  per tube
Carbomer (Carbopol 980 NF) 
20 mg
Excipients: cetrimide, sorbitol, sodium hydroxide, water for injectable preparations.

Indications

Symptomatic treatment of dry eye syndrome.

Dosage and administration

Administer as eye instillations at a rate of 3 or 4 instillations per day into the lower conjunctival sac.


Contraindications

  • Hypersensitivity to the active substance or to any of the excipients listed in section Composition.
  • History of allergy to cetrimide.

Warnings and precautions

Do not leave the tube open after use.

Do not inject, do not swallow.

Do not touch the eye with the tip of the tube.

Any opened tube must be used within one month.


Interactions

Drug interactions
If concomitant treatment with another eye drop is given, wait 15 minutes between the two instillations.

Fertility, pregnancy and breastfeeding

Given the available data, use in pregnant or breastfeeding women is possible.


Driving and using machines

A brief visual disturbance may occur after instillation of the product.

Adverse effects

Possibility of a transient visual disturbance after instillation until the gel spreads evenly over the surface of the eye.

Intolerance reactions to one of the components of this medicine may very rarely occur, such as irritation, scleritis, eyelid oedema.

Reporting of suspected adverse reactions:

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continuous monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals should report any suspected adverse reaction via the national reporting system: National Agency for the Safety of Medicines and Health Products (ANSM) and the network of Regional Pharmacovigilance Centres. Website: https://signalement.social-sante.gouv.fr.


Overdose

In case of overdose, rinse with sterile physiological saline.


Pharmacodynamics

Pharmacotherapeutic class: Lacrimal substitution (ATC code: S01XA20).

Lacrigel is a colourless and transparent gel.

The product is isotonic with tears; it contains Carbopol 980, a polyacrylic acid used as a gelling agent, and cetrimide as a preservative. Its rheological behaviour allows it to be administered as instillations.

Based on these properties, it is prescribed as a substitute product for tears, in cases of insufficiency or alteration of lacrimal secretion.

Its corneal bioadhesion time is seven times greater than that of polyvinyl alcohol.

This persistence of an effective concentration in the tear film results in a reduction in the frequency of administration.


Storage conditions

Shelf life
3 years.

Do not refrigerate. Do not freeze.

After opening:
To be used within one month.

HANDLING/DISPOSAL INSTRUCTIONS

No special requirements.


Prescription, supply and reimbursement

Marketing authorisation (AMM) 3400933521134 (1992, SmPC rev 01.12.2022).
   
Price: 2,99 euros (tube of 10 g).
Social Security reimbursement at 65 %. Collect.


EUROPHTA Laboratories
2, rue du Gabian. MC 98000 Monaco
Tel: 00 377 97 77 72 72. Fax: 00 377 97 77 72 70

Source: VIDAL · Updated on 10/11/2026. This information does not replace advice from a healthcare professional.